ODM-207

CAS No. 1801503-93-4

ODM-207( BET-IN-4 | ODM-207 | ODM207 )

Catalog No. M26070 CAS No. 1801503-93-4

BET-IN-4 is a potent BRD4 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 92 In Stock
5MG 84 In Stock
10MG 136 In Stock
25MG 249 In Stock
50MG 351 In Stock
100MG 496 In Stock
200MG 682 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ODM-207
  • Note
    Research use only, not for human use.
  • Brief Description
    BET-IN-4 is a potent BRD4 inhibitor.
  • Description
    BET-IN-4 is a potent BRD4 inhibitor.(In Vitro):BET-IN-4 inhibits BRD4 with an IC50 of ≤ 1 μM.
  • In Vitro
    ODM-207 (Compound 50) is a potent BET bromodomain protein (BRD4) inhibitor, with an IC50 of ≤ 1 μM.
  • In Vivo
    ——
  • Synonyms
    BET-IN-4 | ODM-207 | ODM207
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1801503-93-4
  • Formula Weight
    375.428
  • Molecular Formula
    C22H21N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (26.64 mM)
  • SMILES
    COc1cc2n(Cc3ccccn3)c(=O)c(C)cc2cc1-c1c(C)noc1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kao-Lu Pan, et al. Identification of trans,trans-2,4-decadienal metabolites in mouse and human cells using liquid chromatography-mass spectrometry. Chem Res Toxicol. 2014 Oct 20;27(10):1707-19.
molnova catalog
related products
  • GSK778

    GSK778 is a potent and selective inhibitor of BD1 bromodomain such as BRD2 BD1 (IC50s = 75 nM), BRD3 BD1 (IC50s = 41 nM), BRD4 BD1 (IC50s = 41 nM), and BRDT BD1 (IC50s = 143 nM). GSK778 inhibits proliferation, induces a cell cycle arrest and apoptosis.

  • C-82

    C-82 is a specific CBP/β-catenin antagonist. It inhibits the binding between β-catenin and CBP and increases the binding between β-catenin and p300.

  • CBP/EP300-IN-1

    CBP/EP300-IN-1 is a CBP/EP300 bromodomain inhibitor.